SARS-CoV-2経鼻ワクチン開発での使用例
Intranasal COVID-19 vaccines: From bench to bed.
Alu, A., Chen, L., Lei, H., Wei, Y., Tian, X., ＆ Wei, X. eBioMedicine (2022). 76, 103841.
ALS（筋萎縮性側索硬化症）研究（ヒトiPS細胞から脊髄下位運動ニューロン（LMN）の誘導）での使用例
Protocol for the induction of human spinal motor neurons from human induced pluripotent stem cells for studying amyotrophic lateral sclerosis.
Setsu, S., Morimoto, S., Nakamura, S., Ozawa, F., ＆ Okano, H. STAR protocols (2025). 6(3), 104016.
参考文献
A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective.interfering virus.
Garcin, D. et al. EMBO J. 1995. 14:6087-6094.
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA.
Calain, P., and L. Roux. J. Virol. 1993. 67:4822-4830.
Paramyxovirus RNA Synthesis and the Requirement for Hexamer Genome Length: the Rule of Six Revisited.
Kolakofsky, D. et al. J Virol. 1998. 72 891-899.
Analysis of tetra- and hepta-nucleotides motifs promoting-1 ribosomal frameshifting in Escherichia coli.
Sharma, V. et al. Nucleic Acids Res. 2014. 42:7210-7225.
WHO/CDS/CSR/NCS/2002.5-WHO Manual on Animal Influenza Diagnosis and Surveillance.
Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Morimoto, S. et al. Genes Cells. 2023. 28:29-41.
